MedPath

Effect of BMP2 versus MTA as a medicament in pulpotomy of primary molars

Phase 3
Conditions
reversible pulpitis.
reversible pulpitis
Registration Number
IRCT2017062434726N1
Lead Sponsor
Vice chancellor for research, Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Exposed vital tooth without signs and symptoms; Teeth with no clinical or radiographic evidence of pulp degeneration; The possibility of proper restoration of the tooth. Exclusion criteria: Teeth with signs and symptoms; Clinical or radiographic evidence of pulp degeneration; physiologic mobility; Evidence of any pathologial root resorption.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: before intervention, 3 months, 6months, 9months and 12 months after intervention. Method of measurement: clinical examination.;Sensitive to percussion. Timepoint: before intervention, 3 months, 6months, 9months and 12 months after intervention. Method of measurement: clinical examination.;Swelling. Timepoint: before intervention, 3 months, 6months, 9months and 12 months after intervention. Method of measurement: clinical examination.;Sinus tract. Timepoint: before intervention, 3 months, 6months, 9months and 12 months after intervention. Method of measurement: clinical examination.;Pathologic mobility. Timepoint: before intervention, 3 months, 6months, 9months and 12 months after intervention. Method of measurement: clinical examination.
Secondary Outcome Measures
NameTimeMethod
Internal resorption. Timepoint: before intervention, 3months, 6months, 9months and 12months after intervention. Method of measurement: radigraphic examination.;External resorption. Timepoint: before intervention, 3months, 6months, 9months and 12months after intervention. Method of measurement: radigraphic examination.;PDL widening. Timepoint: before intervention, 3months, 6months, 9months and 12months after intervention. Method of measurement: radigraphic examination.;Radiolucency. Timepoint: before intervention, 3months, 6months, 9months and 12months after intervention. Method of measurement: radigraphic examination.
© Copyright 2025. All Rights Reserved by MedPath